BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//LifeSci Events - ECPv6.15.11//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:LifeSci Events
X-ORIGINAL-URL:https://lifescievents.com
X-WR-CALDESC:Events for LifeSci Events
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260518T110000
DTEND;TZID=America/New_York:20260518T123000
DTSTAMP:20260429T181824
CREATED:20260415T171240Z
LAST-MODIFIED:20260429T165506Z
UID:3002-1779102000-1779107400@lifescievents.com
SUMMARY:Rapid Medical Virtual KOL Event Featuring DISTALS Clinical Trial Results: First Positive Data in MeVO Distal Ischemic Stroke Segment\, Featuring TIGERTRIEVER™ 13
DESCRIPTION:Join Rapid Medical for a virtual key opinion leader (KOL) event featuring Ronen Eckhouse\, Co-Founder & CEO of Rapid Medical\, alongside leading stroke experts Jeffrey Saver\, MD (UCLA) and Shahram Majidi\, MD (Mount Sinai)\, who will provide clinical perspectives on the evolving treatment paradigm in ischemic stroke. \nThe discussion will provide clinical perspectives on a major advancement in ischemic stroke treatment\, including an overview of the new data from Rapid Medical’s DISTALS study evaluating the TIGERTRIEVER™ 13 platform. The first positive clinical results in the emerging medium vessel occlusion (MeVO) segment— featuring DISTALS study data on the TIGERTRIEVER™ 13. \nTIGERTRIEVER™ is the only active thrombectomy device\, engineered to adapt to patient anatomy\, accelerate clot integration\, and reduce stress on the brain during mechanical thrombectomy procedures. The DISTALS study represents the first randomized evidence demonstrating superiority of a device-based intervention over medical management in distal stroke\, potentially expanding the treatable patient population and reshaping clinical practice. Management will also discuss implications for future treatment protocols and market expansion. \nA live question and answer session will follow the formal presentations. Watch the webcast by clicking this link and logging in with the email address you used to register: https://lifescievents.com/event/yw09tkp5/.
URL:https://lifescievents.com/event/yw09tkp5/
LOCATION:Virtual\, Virtual
ATTACH;FMTTYPE=image/png:https://lifescievents.com/wp-content/uploads/2026/04/Rapid-Medical-Banner.png
END:VEVENT
END:VCALENDAR